Valerio De Stefano

About Valerio De Stefano

Valerio De Stefano, With an exceptional h-index of 79 and a recent h-index of 49 (since 2020), a distinguished researcher at Università Cattolica del Sacro Cuore, specializes in the field of Hematology, Myeloproliferative Neoplasms, Thrombophilia.

His recent articles reflect a diverse array of research interests and contributions to the field:

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study

Obituary of Professor Bruno Bizzi

Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates

IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING …

Safety and efficacy of direct oral anticoagulants in cirrhotic and non-cirrhotic patients with splanchnic vein thrombosis: preliminary results from sapient study

Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study

Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

Valerio De Stefano Information

University

Position

Full Professor of Hematology Italy

Citations(all)

26328

Citations(since 2020)

8773

Cited By

19223

hIndex(all)

79

hIndex(since 2020)

49

i10Index(all)

299

i10Index(since 2020)

181

Email

University Profile Page

Università Cattolica del Sacro Cuore

Google Scholar

View Google Scholar Profile

Valerio De Stefano Skills & Research Interests

Hematology

Myeloproliferative Neoplasms

Thrombophilia

Top articles of Valerio De Stefano

Title

Journal

Author(s)

Publication Date

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

Annals of Hematology

Jean-Jacques Kiladjian

Francisca Ferrer Marin

Haifa Kathrin Al-Ali

Alberto Alvarez-Larrán

Eloise Beggiato

...

2024/3/4

Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study

European Journal of Haematology

Alexandre Theocharides

Heinz Gisslinger

Valerio De Stefano

Vincenzo Accurso

Alessandra Iurlo

...

2024/3

Obituary of Professor Bruno Bizzi

Mediterranean Journal of Hematology and Infectious Diseases

Valerio De Stefano

2024

Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates

International Journal of Laboratory Hematology

G Zini

P Chiusolo

E Rossi

E Di Stasio

S Bellesi

...

2024/2/8

IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING …

Mediterranean Journal of Hematology and Infectious Diseases

Ugo Testa

Giuseppe Leone

Elvira Pelosi

Germana Castelli

Valerio De Stefano

2024/4/30

Safety and efficacy of direct oral anticoagulants in cirrhotic and non-cirrhotic patients with splanchnic vein thrombosis: preliminary results from sapient study

Alla Adelkhanova

Prakash Raj Oli

Vivek Jha

Dhan B Shrestha

Jurgen Shtembari

...

2023/11/7

Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study

Blood Cancer Journal

Arianna Ghirardi

Alessandra Carobbio

Paola Guglielmelli

Alessandro Rambaldi

Valerio De Stefano

...

2024/4/22

Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

Advances in therapy

Philippe Moreau

María-Victoria Mateos

Maria Esther Gonzalez Garcia

Hermann Einsele

Valerio De Stefano

...

2024/2

Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial

Blood Advances

Maria Gabriella Mazzucconi

Francesco Rodeghiero

Giuseppe Avvisati

Valerio De Stefano

Luigi Gugliotta

...

2024/3/26

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes

Annals of Hematology

Tiziano Barbui

Alessandra Carobbio

Valerio De Stefano

Alberto Alvarez-Larran

Arianna Ghirardi

...

2024/2

P1305: NEPA VERSUS ONDANSETRON FOR THE PREVENTION OF CINV IN PATIENTS WITH MULTIPLE MYELOMA OR LYMPHOMA UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. A MONOCENTRIC REAL …

HemaSphere

Idanna Innocenti

Annamaria Tomasso

Antonio Mosca

Giulia Benintende

Michela Colalelli

...

2023/8/1

P971: EFFECT OF DARATUMUMAB ON STEM CELL YIELDS IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: REPORT FROM THE MULTIPLE MYELOMA LAZIO GROUP.

HemaSphere

Francesca Fazio

Mauro Passucci

Chiara Lisi

Jacopo Micozzi

Luana Fianchi

...

2023/8/1

P-325 Standard of care (SOC) outcomes in the last 3 years in patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM): the first pooled analysis of …

Clinical Lymphoma Myeloma and Leukemia

Katja Weisel

Maria-Victoria Mateos

Maria Esther Gonzalez Garcia

Max Bittrich

Joanne Lindsey-Hill

...

2023/9/1

The impact of education on patients’ psycho-emotional status during allogeneic hematopoietic stem cell transplantation: a multicenter prospective study by thes Gruppo Italiano …

Journal of Psychosocial Oncology

Marco Cioce

Ivan Borrelli

Lorella Cappucciati

Manuela Giori

Giorgia Gobbi

...

2023/11/2

Coagulopathy in patients with low/intermediate risk acute promyelocytic leukemia treated with first line arsenic trioxide in combination with all-trans retinoic acid: a …

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

Simona Sica

2023

Identifying patients with polycythemia vera at risk of thrombosis after hydroxyurea initiation: the Polycythemia Vera—Advanced Integrated Models (PV-AIM) Project

Biomedicines

Srdan Verstovsek

Ivan Krečak

Florian H Heidel

Valerio De Stefano

Kenneth Bryan

...

2023/7/7

Incidence of blast phase in myelofibrosis according to anemia severity

EJHaem

Barbara Mora

Margherita Maffioli

Elisa Rumi

Paola Guglielmelli

Marianna Caramella

...

2023/8

MPN-193 Incidence of Blast Phase in Myelofibrosis According to Anemia Severity

Clinical Lymphoma Myeloma and Leukemia

Barbara Mora

Margherita Maffioli

Elisa Rumi

Paola Guglielmelli

Marianna Caramella

...

2023/9/1

Science and scientists under attack

Bleeding, Thrombosis and Vascular Biology

Valerio De Stefano

2023/5/23

PB2611: EVANS SYNDROME: DISEASE AWARENESS AND CLINICAL MANAGEMENT IN A NATION-WIDE ITALIAN SURVEY

HemaSphere

Bruno Fattizzo

Valentina Carrai

Monica Crugnola

Erminia Baldacci

Marta Bellini

...

2023/8/1

See List of Professors in Valerio De Stefano University(Università Cattolica del Sacro Cuore)